Hans J. Woerle
0000-0003-2595-1411
Publication & Citation Trends
Publications
103 total
Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trial. OA
Cited by 27
Semantic Scholar
Empagliflozin compared with glimepiride in metformin‐treated patients with type 2 diabetes: 208‐week data from a masked randomized controlled trial OA
Cited by 43
Semantic Scholar
The potential role and rationale for treatment of heart failure with sodium–glucose co‐transporter 2 inhibitors OA
Cited by 143
Semantic Scholar
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke - Reply. OA
Cited by 2
Semantic Scholar
Linagliptin as add‐on to empagliflozin and metformin in patients with type 2 diabetes: Two 24‐week randomized, double‐blind, double‐dummy, parallel‐group trials
Cited by 48
Semantic Scholar
Efficacy and safety of empagliflozin in patients with type 2 diabetes from Asian countries: pooled data from four phase III trials
Cited by 18
Semantic Scholar
Research Topics
Diabetes Treatment and Management
(81)
Pancreatic function and diabetes
(46)
Metabolism, Diabetes, and Cancer
(41)
Diabetes Management and Research
(30)
Diet and metabolism studies
(12)
Affiliations
Boehringer Ingelheim (Germany)
Universität Ulm
Ibero American University
Boehringer Ingelheim (Taiwan)
Bracknell and Wokingham College